EMAIL THIS PAGE TO A FRIEND

Critical reviews in clinical laboratory sciences

Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects.


PMID 2647414

Abstract

Human IgG consists of two identical heavy (H) chains and two identical light (L) chains joined by interchain disulfide bridges. Heterogeneity in the amino acid sequences of the H and L polypeptides results in at least three types of IgG variants at the structural and genetic levels. The four isotypic forms are IgG1, IgG2, IgG3, and IgG4, which share extensive homologies in the primary structure of their H chains. As a result, the subclasses cross-react antigenically, but they can be differentiated on the basis of subtle architectural dissimilarities. The biological and effector properties of the IgG isotypes have been associated, in part, with their structural differences. Genes determining the synthesis of human IgG heavy chains are located on chromosome 14. In several clinical situations the isotypes appear to be regulated or expressed in patterns reflecting the gene arrangement. The numeric designations of the subclasses correspond to the order of their proportional amounts in healthy adult serum: IgG1 greater than IgG2 greater than IgG3 greater than IgG4. Awareness of the importance of the roles of the four IgG isotypes in human health has steadily increased since they were first described in the 1960s. The recognition that deficits or increases in selected IgG subclasses may have clinical consequences has prompted considerable interest in quantifying the four isotypes in clinical specimens. In particular, deficiencies of IgG2, IgG3, and IgG4, singly or combined, are associated with chronic infections which may not be readily recognized in otherwise healthy people with normal serum total IgG concentrations. Different assay methods using polyclonal or monoclonal antisera with various calibrants have been applied; however, no standardized method exists at the present. IgG deficits are associated with gene defects and are acquired in secondary immunodeficiencies in conjunction with other disorders. IgG isotype selectivity has been recognized in autoimmune diseases and in response to carbohydrate and protein antigens derived from pathogenic microorganisms and common allergens.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A3400 Anti-Human IgA (α-chain specific)−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A0293 Anti-Human IgG (Fab specific)−Peroxidase antibody produced in goat, affinity isolated antibody
SAB4200791
Anti-Human IgG (Fab specific)-Peroxidase antibody, Mouse monoclonal, clone GG-6, purified from hybridoma cell culture
A3316 Anti-Human IgG (Fc Specific)−Agarose antibody produced in goat, affinity isolated antibody, PBS suspension
A9544 Anti-Human IgG (Fc specific)−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A0170 Anti-Human IgG (Fc specific)−Peroxidase antibody produced in goat, affinity isolated antibody
SAB4200743
Anti-Human IgG (Fc specific)-Peroxidase antibody, Mouse monoclonal, clone HP-6017, purified from hybridoma cell culture
SAB4200790
Anti-Human IgG (Fc specific)-Peroxidase antibody, Mouse monoclonal, clone GG-7, purified from hybridoma cell culture
SAB4200713
Anti-Human IgG (γ-chain specific) antibody, Mouse monoclonal, clone GG-5, purified from hybridoma cell culture
A3312
Anti-Human IgG (γ-chain specific), F(ab′)2 fragment−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous glycerol solution
F1641 Anti-Human IgG (γ-chain specific), F(ab′)2 fragment–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A2290 Anti-Human IgG (γ-chain specific), F(ab′)2 fragment−Peroxidase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
P8047 Anti-Human IgG (γ-chain specific), F(ab′)2 fragment−R-Phycoerythrin antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A6656 Anti-Human IgG (γ-chain specific)−Agarose antibody produced in goat, IgG fraction of antiserum, saline suspension
A3187 Anti-Human IgG (γ-chain specific)−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous glycerol solution
A3150 Anti-Human IgG (γ-chain specific)−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous glycerol solution
B1140 Anti-Human IgG (γ-chain specific)-Biotin antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A6029
Anti-Human IgG (γ-chain specific)−Peroxidase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A8419 Anti-Human IgG (γ-chain specific)−Peroxidase antibody produced in goat, IgG fraction of antiserum, buffered aqueous solution
P9170 Anti-Human IgG (γ-chain specific)−R-Phycoerythrin antibody produced in goat, affinity isolated antibody, buffered aqueous solution
I1886 Anti-Human IgG (whole molecule) antibody produced in goat, IgG fraction of antiserum, buffered aqueous solution
A1543 Anti-Human IgG (whole molecule)−Alkaline Phosphatase antibody produced in goat, IgG fraction of antiserum, buffered aqueous solution
52526 Anti-Human IgG (whole molecule)−Atto 488 antibody produced in goat, ~1 mg/mL
F3512 Anti-Human IgG (whole molecule)−FITC antibody produced in goat, IgG fraction of antiserum, buffered aqueous solution
A8667 Anti-Human IgG (whole molecule)−Peroxidase antibody produced in goat, IgG fraction of antiserum, buffered aqueous solution
A8792 Anti-Human IgG (whole molecule)−Peroxidase antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
A2064 Anti-Human IgG−Alkaline Phosphatase antibody, Mouse monoclonal, clone GG-5, purified from hybridoma cell culture
SAB4200768
Anti-Human IgG1-Peroxidase antibody, Mouse monoclonal, clone 8c/6-39, purified from hybridoma cell culture
SAB4200783
Anti-Human IgG2 antibody, Mouse monoclonal, clone HP-6014, purified from hybridoma cell culture
A6284 Human IgG−Agarose, saline suspension